Dimebon
Sponsors
Medivation, Inc., Pfizer
Conditions
Alzheimer DiseaseAlzheimer's DiseaseHealthy VolunteersHepatic FailureHuntington DiseaseHuntington's Disease
Phase 1
Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
CompletedNCT00387270
Start: 2006-10-31End: 2007-03-31Updated: 2008-01-04
A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects
CompletedNCT00825084
Start: 2009-02-28End: 2009-05-31Updated: 2011-04-26
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
CompletedNCT00824590
Start: 2009-02-28End: 2009-10-31Updated: 2009-12-30
A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
CompletedNCT00827034
Start: 2009-02-28End: 2009-04-30Updated: 2018-10-16
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
CompletedNCT00829816
Start: 2008-12-31End: 2010-08-31Updated: 2015-11-10
Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function
CompletedNCT00831532
Start: 2009-02-28End: 2009-08-31Updated: 2009-09-16
Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects
CompletedNCT00831506
Start: 2009-02-28End: 2009-05-31Updated: 2009-06-12
A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults
CompletedNCT00907322
Start: 2009-06-30End: 2009-07-31Updated: 2009-07-22
A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users
CompletedNCT00975481
Start: 2009-10-31End: 2010-02-28Updated: 2013-04-02
Phase 2
Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
CompletedNCT00377715
Start: 2005-09-30Updated: 2015-11-11
A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
CompletedNCT00497159
Start: 2007-07-31End: 2008-06-30Updated: 2015-06-08
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
TerminatedNCT00704782
Start: 2008-04-30End: 2010-08-31Updated: 2015-12-10
Phase 3
A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
CompletedNCT00675623
Start: 2008-05-31Updated: 2016-09-27
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
CompletedNCT00829374
Start: 2009-03-31End: 2011-12-31Updated: 2016-09-27
A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease
CompletedNCT00838110
Start: 2009-02-28End: 2010-01-31Updated: 2018-12-06
A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease
CompletedNCT00920946
Start: 2009-07-31Updated: 2016-10-12
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
TerminatedNCT00939783
Start: 2009-09-30End: 2010-08-31Updated: 2012-11-14
An Extension of the CONCERT Protocol (DIM18)
TerminatedNCT01152216
Start: 2010-04-30Updated: 2016-09-27